Literature DB >> 25618904

Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia.

F T Gossink1, A Dols1, C J Kerssens2, W A Krudop3, B J Kerklaan4, Ph Scheltens3, M L Stek2, Y A L Pijnenburg1.   

Abstract

INTRODUCTION: The frontotemporal dementia (FTD) consortium criteria (2011) emphasise the importance of distinguishing possible and probable behavioural variant FTD (bvFTD). A significant number of possible patients with bvFTD do not show functional decline and remain with normal neuroimaging over time, thus exhibiting the bvFTD phenocopy syndrome. A neurodegenerative nature is unlikely but an alternative explanation is missing. Our aim was to detect psychiatric conditions underlying the bvFTD phenocopy syndrome after extensive evaluation.
METHODS: We included patients with the bvFTD phenocopy syndrome whereby patients with probable bvFTD served as a control group. Patients had to have undergone both neurological and psychiatric evaluation. Their charts were reviewed retrospectively. Using both qualitative and quantitative methods, psychiatric and psychological conditions associated with the clinical syndrome were determined in both groups and their relative frequencies were compared.
RESULTS: Of 181 suspected bvFTD cases, 33 patients with bvFTD phenocopy syndrome and 19 with probable bvFTD were included. Recent life events, relationship problems and cluster C personality traits were the most prevalent psychiatric/psychological conditions. The frequency of these conditions was higher in the group of patients with the bvFTD phenocopy syndrome (n=28) compared to the probable bvFTD group (n=9) (χ(2) p<0.05).
CONCLUSIONS: This is the first study thoroughly exploring psychiatric causes of the bvFTD phenocopy syndrome, revealing that in most cases multiple factors played a contributory role. Our study gives arguments for neurological and psychiatric collaboration when diagnosing bvFTD. Prompt diagnosis of treatable psychiatric conditions is to be gained. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  BEHAVIOURAL DISORDER; DEMENTIA; FRONTAL LOBE; NEUROPSYCHIATRY

Mesh:

Year:  2015        PMID: 25618904     DOI: 10.1136/jnnp-2014-308284

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

Review 1.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

2.  Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy.

Authors:  Ignacio Illán-Gala; Victor Montal; Sergi Borrego-Écija; Eduard Vilaplana; Jordi Pegueroles; Daniel Alcolea; Belén Sánchez-Saudinós; Jordi Clarimón; Janina Turón-Sans; Nuria Bargalló; Sofía González-Ortiz; Howard J Rosen; Maria Luisa Gorno-Tempini; Bruce L Miller; Albert Lladó; Ricard Rojas-García; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea
Journal:  Brain       Date:  2019-04-01       Impact factor: 13.501

Review 3.  Premorbid de novo artistic creativity in frontotemporal dementia (FTD) syndromes.

Authors:  Felix Geser; Tibor C G Mitrovics; Johannes Haybaeck; Deniz Yilmazer-Hanke
Journal:  J Neural Transm (Vienna)       Date:  2021-10-07       Impact factor: 3.575

Review 4.  Frontotemporal Dementias.

Authors:  Elizabeth C Finger
Journal:  Continuum (Minneap Minn)       Date:  2016-04

5.  The Neuropsychiatric Features of Behavioral Variant Frontotemporal Dementia.

Authors:  Bradley T Peet; Sheila Castro-Suarez; Bruce L Miller
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study.

Authors:  E A J Willemse; P Scheltens; C E Teunissen; E G B Vijverberg
Journal:  Alzheimers Res Ther       Date:  2021-05-18       Impact factor: 6.982

7.  The behavioural variant frontotemporal dementia phenocopy syndrome is a distinct entity - evidence from a longitudinal study.

Authors:  E Devenney; T Swinn; E Mioshi; M Hornberger; K E Dawson; S Mead; J B Rowe; J R Hodges
Journal:  BMC Neurol       Date:  2018-04-28       Impact factor: 2.474

Review 8.  Phenocopy syndrome of behavioral variant frontotemporal dementia: a systematic review.

Authors:  Elizabeth Sakamoto Valente; Paulo Caramelli; Leandro Boson Gambogi; Luciano Inácio Mariano; Henrique Cerqueira Guimarães; Antônio Lúcio Teixeira; Leonardo Cruz de Souza
Journal:  Alzheimers Res Ther       Date:  2019-04-01       Impact factor: 6.982

Review 9.  Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.

Authors:  Simon Ducharme; Annemiek Dols; Robert Laforce; Emma Devenney; Fiona Kumfor; Jan van den Stock; Caroline Dallaire-Théroux; Harro Seelaar; Flora Gossink; Everard Vijverberg; Edward Huey; Mathieu Vandenbulcke; Mario Masellis; Calvin Trieu; Chiadi Onyike; Paulo Caramelli; Leonardo Cruz de Souza; Alexander Santillo; Maria Landqvist Waldö; Ramon Landin-Romero; Olivier Piguet; Wendy Kelso; Dhamidhu Eratne; Dennis Velakoulis; Manabu Ikeda; David Perry; Peter Pressman; Bradley Boeve; Rik Vandenberghe; Mario Mendez; Carole Azuar; Richard Levy; Isabelle Le Ber; Sandra Baez; Alan Lerner; Ratnavalli Ellajosyula; Florence Pasquier; Daniela Galimberti; Elio Scarpini; John van Swieten; Michael Hornberger; Howard Rosen; John Hodges; Janine Diehl-Schmid; Yolande Pijnenburg
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

10.  Structural and functional brain abnormalities place phenocopy frontotemporal dementia (FTD) in the FTD spectrum.

Authors:  Rebecca M E Steketee; Rozanna Meijboom; Esther E Bron; Robert Jan Osse; Inge de Koning; Lize C Jiskoot; Stefan Klein; Frank Jan de Jong; Aad van der Lugt; John C van Swieten; Marion Smits
Journal:  Neuroimage Clin       Date:  2016-04-10       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.